Global Analyst Research Settlements

Core Scientific, Inc. Announces Filing of Amended Plan of Reorganization and Extension of Equity Rights Offering Subscription Deadline

Retrieved on:

Friday, December 29, 2023

Blockchain, Software, Data Analytics, Cryptocurrency, Hardware, Data Management, Professional Services, Technology, Plan, Court, Global Analyst Research Settlements, OTC, United States bankruptcy court, Rights, Disclosure, Science

Core Scientific, Inc. (OTC: CORZQ) (“Core Scientific“ or the “Company”), a leader in high-performance blockchain computing data centers and software solutions, today announced the filing of an amended plan of reorganization (the “Plan”) and extension of the subscription deadline for its Equity Rights Offering to January 5, 2024.

Key Points:

Core Scientific, Inc. (OTC: CORZQ) (“Core Scientific“ or the “Company”), a leader in high-performance blockchain computing data centers and software solutions, today announced the filing of an amended plan of reorganization (the “Plan”) and extension of the subscription deadline for its Equity Rights Offering to January 5, 2024.
While subject to further finalization, the Plan reflects the Global Settlement and represents another step towards confirmation and exit from Chapter 11.
As a result of rescheduling the Combined Hearing, the deadline for participating in the Equity Rights Offering has been extended to Friday, January 5, 2024.
The Rights Offering Procedures and Subscription Form can be found and submitted by clicking here .

Core Scientific, Inc. Announces Agreement in Principle on Terms of Chapter 11 Global Plan Settlement with All Key Stakeholders and Extension of Equity Rights Offering Subscription Deadline

Retrieved on:

Thursday, December 21, 2023

Core Scientific, Inc. (OTC: CORZQ) ("Core Scientific" or the “Company”), a leader in high-performance blockchain computing data centers and software solutions, today announced it has reached an agreement in principle with all key stakeholders on the terms of a global settlement (the “Global Settlement”) of its Chapter 11 cases.

Key Points:

Core Scientific, Inc. (OTC: CORZQ) ("Core Scientific" or the “Company”), a leader in high-performance blockchain computing data centers and software solutions, today announced it has reached an agreement in principle with all key stakeholders on the terms of a global settlement (the “Global Settlement”) of its Chapter 11 cases.
“The global settlement removes key hurdles to our anticipated emergence from Chapter 11 in January,” said Adam Sullivan, Core Scientific’s Chief Executive Officer.
In light of the Global Settlement and adjournment of the Combined Hearing, the deadline for participating in the Equity Rights Offering has been extended to Thursday, December 28, 2023.
The Rights Offering Procedures and Subscription Form can be found and submitted by clicking here .

FTX Digital Markets Limited ("FTX Digital Markets") has successfully negotiated a landmark settlement with FTX Trading Ltd. and its affiliated debtors (together, the "FTX Debtors") which will see assets combined from the respective estates, enabling a coo

Retrieved on:

Tuesday, December 19, 2023

Eligibility, Intellectual property, Sale, Bankruptcy, Supreme court, FTX, PwC, JOL, Global Analyst Research Settlements, Non-fungible token, FTT, Joint, United States bankruptcy court, Cryptocurrency

The Global Settlement Agreement includes important agreements between FTX Digital Markets and the FTX Debtors with respect to the monetisation and distribution of the assets of the FTX group.

Key Points:

The Global Settlement Agreement includes important agreements between FTX Digital Markets and the FTX Debtors with respect to the monetisation and distribution of the assets of the FTX group.
The valuation of digital assets at the petition date will reflect a consensus approach between FTX Digital Markets and the FTX Debtors, approved by both Courts.
FTT interests against FTX Digital Markets and the FTX Debtors will be treated as equity and not receive any recovery.
FTX.com customer preference claims will be reconciled in a common, jointly-administered process between FTX Digital Markets and the FTX Debtors.

FTX Debtors and FTX Digital Markets (Bahamas) Announce Global Settlement

Retrieved on:

Tuesday, December 19, 2023

United States bankruptcy court, Policy, Multimedia, KYC, Bankruptcy, Supreme court, Court, FTX, Global Analyst Research Settlements, Non-fungible token, FTT, Joint, Debtor, Disclosure, Cryptocurrency

WILMINGTON, Del., Dec. 19, 2023 /PRNewswire/ -- FTX Trading Ltd. (d.b.a. FTX.com) and its affiliated debtors (together, the "FTX Debtors") announced today that they have reached a global settlement with Brian C. Simms KC, Peter Greaves and Kevin Cambridge, the Joint Official Liquidators (the "JOLs") on behalf of FTX Digital Markets Ltd. ("FTX Digital Markets"), the wholly-owned subsidiary of the Debtors that is subject to a liquidation proceeding in The Bahamas. The settlement is reflected in a Global Settlement Agreement, signed by the parties today. The Global Settlement Agreement is subject to the approval of the U.S. Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") and the Supreme Court of the Bahamas Court (the "Bahamas Court" and, together with the Bankruptcy Court, the "Courts"), which approvals the parties have agreed to seek promptly.

Key Points:

FTX.com) and its affiliated debtors (together, the "FTX Debtors") announced today that they have reached a global settlement with Brian C. Simms KC, Peter Greaves and Kevin Cambridge, the Joint Official Liquidators (the "JOLs") on behalf of FTX Digital Markets Ltd. ("FTX Digital Markets"), the wholly-owned subsidiary of the Debtors that is subject to a liquidation proceeding in The Bahamas.
customer preferences will be reconciled in a jointly-administered process, pursuant to which the FTX Debtors and FTX Digital Markets will apply a consensual preference policy informed by the settlement announced by the FTX Debtors on October 16, 2023.
The FTX Debtors and FTX Digital Markets currently anticipate that eligible FTX.com customers will be able to make this election either in response to Chapter 11 plan ballots distributed by the FTX Debtors or a separate proof of debt form filed in FTX Digital Markets' liquidation proceeding.
The Global Settlement Agreement also includes important agreements between the FTX Debtors and FTX Digital Markets with respect to the monetization of the assets of the FTX group and inter-estate funding.

EQS-News: Steinhoff International Holdings N.V. : SRF DISTRIBUTION UPDATE

Retrieved on:

Tuesday, May 9, 2023

Steinhoff, JSE Limited, Global Analyst Research Settlements, SRF, Frankfurt Stock Exchange, News, Security (finance), Insurance, Cryptocurrency

The SRF, with the assistance of the appointed Claims Administrator, has since been hard at work administering and verifying the claims received.

Key Points:

The SRF, with the assistance of the appointed Claims Administrator, has since been hard at work administering and verifying the claims received.
The SRF has informed Steinhoff that it will commence with the distribution of cash recoveries to individual and institutional claimants holding valid and accepted claims on a rolling basis as from 10 May 2023.
Marcel Windt, Chairperson of the SRF said: “We are extremely pleased to have reached the stage in this process where we are able to distribute payments to eligible claimants.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Collaboratively Developing Transmission, Computing, and Storage Power to Stride Towards the Intelligent World

Retrieved on:

Sunday, April 23, 2023

Global Analyst Research Settlements, Data-rate units, Huawei, Stride Toward Freedom, Speech, Internet of things, Dean, Data collection, Huachung University, Research, Carbon, Communication, ICT, School, China Unicom, Architecture, Intelligence, Computer science, Mobile phone

SHENZHEN, China, April 23, 2023 /PRNewswire/ -- On April 20th, Huawei held the Striding Towards the Intelligent World Session at Global Analyst Summit 2023.

Key Points:

SHENZHEN, China, April 23, 2023 /PRNewswire/ -- On April 20th, Huawei held the Striding Towards the Intelligent World Session at Global Analyst Summit 2023.
Peng Song, Huawei's President of ICT Strategy & Marketing, delivered the keynote speech titled Striding Towards the Intelligent World Through Continuous Innovation.
Third, Huawei is building reliable storage facilities to ensure more data can be stored, quickly transmitted, and efficiently used.
"Moving forward, we will continue innovating to help customers build leading digital infrastructure, accelerating our journey towards the intelligent world," said Peng.

Collaboratively Developing Transmission, Computing, and Storage Power to Stride Towards the Intelligent World

Retrieved on:

Sunday, April 23, 2023

SHENZHEN, China, April 22, 2023 /PRNewswire/ -- On April 20th, Huawei held the Striding Towards the Intelligent World Session at Global Analyst Summit 2023.

Key Points:

SHENZHEN, China, April 22, 2023 /PRNewswire/ -- On April 20th, Huawei held the Striding Towards the Intelligent World Session at Global Analyst Summit 2023.
Peng Song, Huawei's President of ICT Strategy & Marketing, delivered the keynote speech titled Striding Towards the Intelligent World Through Continuous Innovation.
The session attracted analysts, experts, scholars, and journalists from around the world.
"Moving forward, we will continue innovating to help customers build leading digital infrastructure, accelerating our journey towards the intelligent world," said Peng.

Navidea Biopharmaceuticals Announces Oral Ruling in Case Involving Attorney’s Fees

Retrieved on:

Thursday, September 1, 2022

v. Navidea Biopharmaceuticals, Inc. and Macrophage Therapeutics, Inc., awarding Capital Royalty Group (CRG) $2,572,937.61 in attorneys fees on their breach of contract claims against Navidea and Macrophage Therapeutics (MT).

Key Points:

v. Navidea Biopharmaceuticals, Inc. and Macrophage Therapeutics, Inc., awarding Capital Royalty Group (CRG) $2,572,937.61 in attorneys fees on their breach of contract claims against Navidea and Macrophage Therapeutics (MT).
v. Navidea Biopharmaceuticals, Inc. and Macrophage Therapeutics, Inc., and by pursuing a suit against CRG in the State of Ohio.
Navidea is disappointed in the Courts ruling and does not believe the law and the facts presented at the trial support the ruling against it.
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) is a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics.

Morningstar to Unite Two Forward-Looking Rating Systems into One: The Morningstar Medalist Rating

Retrieved on:

Wednesday, August 31, 2022

CHICAGO, Aug. 31, 2022 /PRNewswire/ -- Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, today announced plans to unite its two forward-looking managed investment ratings—the Morningstar Analyst Rating™ (Analyst Rating) and the Morningstar Quantitative Rating™ for funds (Quantitative Rating)—into a single rating: The Morningstar Medalist Rating™ (Medalist Rating). This change is slated to take place in the second quarter of 2023."Over the last decade, the Morningstar Analyst Rating and Morningstar Quantitative Rating have empowered investor success by accurately sorting funds based on future performance relative to a benchmark or its peers. By combining these two ratings, we are building on that strength while also simplifying the way we present information to investors," said Lee Davidson, head of manager and quantitative research at Morningstar. "This should make it easier for investors to analyze, select, and monitor managed investments amid an ever-expanding sea of choices."Currently, Morningstar conducts forward-looking assessments of managed investments in two ways: Manager research analysts qualitatively assess managed investments they cover, with those assessments culminating in the Analyst Rating, which takes the form of Gold, Silver, Bronze, Neutral and Negative. Morningstar uses algorithmic techniques to assess managed investments that analysts do not cover. Those quantitative assessments underpin the Quantitative Rating, which takes the form of GoldQ, SilverQ, BronzeQ, NeutralQ, and NegativeQ. By uniting the Analyst Rating and Quantitative Rating under the Medalist Rating banner, Morningstar will move to a common ratings scale of Gold, Silver, Bronze, Neutral and Negative, removing the superscript "Q" designation from the ratings of managed investments assessed quantitatively.The Analyst Rating and Quantitative Rating methodologies will not change and the three pillars—People, Process, and Parent—will continue to form the basis for the ratings. However, to help investors distinguish between pillars assessed by analysts and those assessed quantitatively, Morningstar will continue to apply the superscript "Q" designation to pillar ratings assigned quantitatively.

Key Points:

The change will combine the Morningstar Analyst Rating with the Morningstar Quantitative Rating, making it even simpler for investors to research and select best-in-class managed investments
CHICAGO, Aug. 31, 2022 /PRNewswire/ -- Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, today announced plans to unite its two forward-looking managed investment ratingsthe Morningstar Analyst Rating (Analyst Rating) and the Morningstar Quantitative Rating for funds (Quantitative Rating)into a single rating: The Morningstar Medalist Rating (Medalist Rating).
"Over the last decade, the Morningstar Analyst Rating and Morningstar Quantitative Rating have empowered investor success by accurately sorting funds based on future performance relative to a benchmark or its peers.
By the end of the second quarter of 2023, Morningstar Medalist Ratings will be available in all Morningstar products and platforms globally that currently carry the Morningstar Analyst Rating and the Morningstar Quantitative Rating.
Morningstar's Manager Research Group produces various ratings and assessments including the Morningstar Analyst Rating and the Morningstar Quantitative Rating.

Teva to pay over $4 billion to communities in pending nationwide opioid settlement

Retrieved on:

Wednesday, July 27, 2022

WASHINGTON, July 26, 2022 /PRNewswire/ -- Today, the National Prescription Opiate Litigation Plaintiffs' Executive Committee confirmed that they, alongside the working group of States' Attorneys General, counsel for Native American Tribes and plaintiffs' lawyers representing the States and local communities, have reached an agreement in principle with pharmaceutical manufacturer Teva on the primary financial terms of a nationwide opioid settlement. This agreement follows years of litigation naming Teva as a defendant responsible for fueling the opioid epidemic in America.

Key Points:

This agreement follows years of litigation naming Teva as a defendant responsible for fueling the opioid epidemic in America.
Announced today by Teva, this settlement is contingent upon finalization of terms between the working group and Teva.
This settlement news comes as multidistrict federal litigation and state litigation continues in courtrooms around the country against other companies in the opioid supply chain.
Teva and Allergan were defendants in thattrial until July 12, 2022 when the parties reached a $58M settlement agreement.